sensamove arm sensamove technologies irena barbulovic-nad stefanie blain geneviève gavigan rohini...

20
SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th , 2005

Upload: theodore-austin

Post on 04-Jan-2016

225 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

SensaMove ArmSensaMove Technologies

Irena Barbulovic-NadStefanie Blain

Geneviève GaviganRohini Gupta

Jennifer KohlenbergGolnaz Vahedi

November 30th, 2005

Page 2: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,
Page 3: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Where’s my change? Problems with current prosthetics (suggested from literature

and by individual who uses four prosthetic limbs)

Weight Audible noise Unnatural appearance Durability Temperature Speed of arm’s movement Ease of Use Functionality

Page 4: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Objective Develop a prosthetic that improves upon:

Functionality

Weight

Audible noise

Ease of use

Page 5: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Outline Highlights of technology Biopsychosocial implications FDA approval Commercialization Questions

Page 6: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

The SensaMove Arm

MMG electrodes

Artificial muscles

90º ROM elbow

Electroactive Polymer sensors

Supinating / pronating wrist

Open / close hand

User-trainedMicroprocessor

Page 7: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Sensors

Finger pressure sensors

Grip pressure sensor

EAP locationsGrip

Page 8: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Artificial Muscles

E.A. Moschou et al. / Sensors and Actuators B xxx (2005) xxx–xxx

Hydrogel

Artificial muscle

Muscle conformation

Page 9: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Training

Artificial Neural Network

User

Elbow

HandWrist

Page 10: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

ICF Model

Page 11: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Get to Market: FDA Approval

Step 1defined by 201(h) in FD&C Act

Step 2no substantially equivalent PMA $90,910“de novo” process as Class II under 513(f)(2) 510(k) $3,066

Step 3performance standardsclinical performance datapatient registriespost market surveillanceguidelines

Step 1 Step 2 Step 3“Medical Device”

Classify Device

Data for Market

Submission

Page 12: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Competitors:

Motion Control, Inc.

Otto Bock HealthCare

T.R.S., Inc

Variety Ability Systems Inc.

Page 13: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Can we commercialize?

Page 14: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Commercialization: Market (USA data)

350,000 amputees - 30% upper limb loss

50,000 new amputations/yr - 20% upper limb

Target Clients: 100,000

Market increase from $5.2 billion in 2005 to $6.8 billion in 2010 (AAGR of 5.5%)

Source: BCC, Inc

Page 15: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Commercialization: The ‘So-So’ R&D:

New techniques in preliminary research

Legal: Concepts: Artificial muscle, MMG, EAP

Commercial: Acceptance – New training

Page 16: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Commercialization: The ‘Good’ Legal:

Patentable: Pressure Sensor, Complete arm People:

Dynamic team Skilled and Resourceful

Commercial: Address unmet needs for prosthetics Reach market in 3 yrs High market potential

Page 17: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Start Up Company

Page 18: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

SensaMove Prosthetics

Lead Product: SensaMove Arm Platform Technology: Feedback Sensors Timeline:

Phase Milestone 6 mnth 1 yr 2 yr 3 yr

Research and Design Detail Design        

Prototype construction Prototype arm        

Testing Client use        

Commercial Production capability        

Page 19: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Total Units Sold 637Cost of Capital 8%Net Present Value $7,514,471.41

Year 1 2 3 4 5 … 10

Growth Rate 50% 50%No. of People Mng. 6 6 6 8 8 10Units Sold 0 0 0 20 30 225Patent Costs -$50,000Legal Fees, Insurance -$20,000 -$20,000 -$20,000 -$20,000 -$20,000 -$20,000Rent & Oprt. Cost -$100,000 -$100,000 -$100,000Equipment -$500,000 -$10,000 -$10,000 -$10,000Material -$50,000 -$280,000 -$420,000 -$3,150,0001 Prototype, 2 Demos -$100,000Marketing -$20,000 -$20,000 -$40,000 -$40,000 -$40,000R&D (subcontracting) -$20,000 -$20,000 -$20,000 -$20,000 -$20,000FDA Approval -$100,000Total Sale* $0 $0 $0 $1,400,000 $2,100,000 $15,750,000

Salaries $0 $0 $0 -$960,000 -$960,000 -$1,200,000Sales Cost (%10) -$140,000 -$210,000 -$1,575,000Tech. Support (%5) -$70,000 -$105,000 -$787,500Training (%3) -$42,000 -$63,000 -$472,500Warranty (5%) -$70,000 -$105,000 -$787,500Net Cash Flow -$120,000 -$160,000 -$660,000 -$352,000 $47,000 $7,587,500

*Price/Unit $70,000; Material Cost/Unit 20%;

Money Money Money

NPV = $7.5 MInvestment = $1.5 M

Page 20: SensaMove Arm SensaMove Technologies Irena Barbulovic-Nad Stefanie Blain Geneviève Gavigan Rohini Gupta Jennifer Kohlenberg Golnaz Vahedi November 30 th,

Technology that FeelsQuestions ?